{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:03Z","timestamp":1785110403599,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI180263"],"award-info":[{"award-number":["R21AI180263"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54470-8","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:28:34Z","timestamp":1779431314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monoclonal antibody development against the Hepatitis C virus core protein enables rapid antigen detection"],"prefix":"10.1038","volume":"16","author":[{"given":"Prince Baffour","family":"Tonto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby Brooke","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"6","key":"54470_CR1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4254\/wjh.v7.i6.831","volume":"7","author":"N Echeverr\u00eda","year":"2015","unstructured":"Echeverr\u00eda, N., Moratorio, G., Cristina, J. & Moreno, P. Hepatitis C virus genetic variability and evolution. World J. Hepatol. 7 (6), 831\u2013845 (2015).","journal-title":"World J. Hepatol."},{"key":"54470_CR2","unstructured":"CDC. Clinical Overview of Hepatitis C 2025 [Available from: https:\/\/www.cdc.gov\/hepatitis-c\/hcp\/clinical-overview\/"},{"key":"54470_CR3","unstructured":"WHO & Hepatitis, C. [ (2025). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"issue":"3","key":"54470_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"Global prevalence","year":"2017","unstructured":"Global prevalence. and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol. Hepatol. 2 (3), 161\u2013176 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"54470_CR5","unstructured":"CDC. Clinical Care of Hepatitis C. [ (2025). Available from: https:\/\/www.cdc.gov\/hepatitis-c\/hcp\/clinical-care\/"},{"key":"54470_CR6","doi-asserted-by":"publisher","first-page":"608760","DOI":"10.3389\/fmed.2021.608760","volume":"8","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. High SVR12 with 8-week course of direct-acting antivirals in adolescents and children with chronic hepatitis C: A comprehensive analysis. Front. Med. 8, 608760 (2021).","journal-title":"Front. Med."},{"issue":"Suppl 1(Suppl 1","key":"54470_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.13673","volume":"38","author":"T Asselah","year":"2018","unstructured":"Asselah, T., Marcellin, P. & Schinazi, R. F. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure? Liver Int. 38 (Suppl 1(Suppl 1), 7\u201313 (2018).","journal-title":"Liver Int."},{"issue":"28","key":"54470_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.15585\/mmwr.mm7228a2","volume":"72","author":"EJ Cartwright","year":"2023","unstructured":"Cartwright, E. J., Patel, P., Kamili, S. & Wester, C. Updated operational guidance for implementing CDC\u2019s recommendations on testing for hepatitis C virus infection. MMWR Morb Mortal. Wkly. Rep. 72 (28), 766\u2013768 (2023).","journal-title":"MMWR Morb Mortal. Wkly. Rep."},{"issue":"Suppl 2(Suppl S","key":"54470_CR9","doi-asserted-by":"publisher","first-page":"e25058","DOI":"10.1002\/jia2.25058","volume":"21","author":"S Fourati","year":"2018","unstructured":"Fourati, S., Feld, J. J., Chevaliez, S. & Luhmann, N. Approaches for simplified HCV diagnostic algorithms. J. Int. AIDS Soc. 21 (Suppl 2(Suppl Suppl 2), e25058 (2018).","journal-title":"J. Int. AIDS Soc."},{"issue":"6","key":"54470_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6906a1","volume":"69","author":"AC Moorman","year":"2020","unstructured":"Moorman, A. C. et al. Testing and clinical management of health care personnel potentially exposed to hepatitis C virus - CDC guidance, United States, 2020. MMWR Recomm Rep. 69 (6), 1\u20138 (2020).","journal-title":"MMWR Recomm Rep."},{"issue":"6","key":"54470_CR11","doi-asserted-by":"publisher","first-page":"e23755","DOI":"10.1002\/jcla.23755","volume":"35","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Jie, W., Ling, J. & Yuanshuai, H. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J. Clin. Lab. Anal. 35 (6), e23755 (2021).","journal-title":"J. Clin. Lab. Anal."},{"issue":"6","key":"54470_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1515\/cclm-2017-0754","volume":"56","author":"C Galli","year":"2018","unstructured":"Galli, C., Julicher, P. & Plebani, M. HCV core antigen comes of age: A new opportunity for the diagnosis of hepatitis C virus infection. Clin. Chem. Lab. Med. 56 (6), 880\u2013888 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"54470_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7326\/M16-0065","volume":"165","author":"JM Freiman","year":"2016","unstructured":"Freiman, J. M. et al. Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: A systematic review and meta-analysis. Ann. Intern. Med. 165 (5), 345\u2013355 (2016).","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"54470_CR14","doi-asserted-by":"publisher","first-page":"e2436","DOI":"10.1002\/rmv.2436","volume":"33","author":"D Sep\u00falveda-Crespo","year":"2023","unstructured":"Sep\u00falveda-Crespo, D. et al. Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta-analysis. Rev. Med. Virol. 33 (3), e2436 (2023).","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"54470_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40249-024-01264-7","volume":"13","author":"A Trevi\u00f1o-Nakoura","year":"2024","unstructured":"Trevi\u00f1o-Nakoura, A. et al. Diagnostic performance of hepatitis C virus core antigen testing for detecting hepatitis C in people living with hepatitis B: A systematic review and meta-analysis. Infect. Dis. Poverty. 13 (1), 89 (2024).","journal-title":"Infect. Dis. Poverty"},{"issue":"11","key":"54470_CR16","doi-asserted-by":"publisher","first-page":"e0313771","DOI":"10.1371\/journal.pone.0313771","volume":"19","author":"S Kanokudom","year":"2024","unstructured":"Kanokudom, S. et al. Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment. PLoS One. 19 (11), e0313771 (2024).","journal-title":"PLoS One"},{"key":"54470_CR17","doi-asserted-by":"publisher","first-page":"105743","DOI":"10.1016\/j.jcv.2024.105743","volume":"175","author":"J Prostko","year":"2024","unstructured":"Prostko, J. et al. Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population. J. Clin. Virol. 175, 105743 (2024).","journal-title":"J. Clin. Virol."},{"key":"54470_CR18","unstructured":"WHO. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis 2016 [Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06"},{"issue":"1","key":"54470_CR19","doi-asserted-by":"publisher","first-page":"2184197","DOI":"10.1080\/19420862.2023.2184197","volume":"15","author":"AL Louren\u00e7o","year":"2023","unstructured":"Louren\u00e7o, A. L. et al. High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions. MAbs 15 (1), 2184197 (2023).","journal-title":"MAbs"},{"issue":"1","key":"54470_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jim.2009.04.004","volume":"345","author":"AS Muerhoff","year":"2009","unstructured":"Muerhoff, A. S. et al. Microheterogeneous monoclonal antibody subspecies with differential hepatitis C virus core antigen binding properties identified by SEC-HPLC. J. Immunol. Methods. 345 (1), 60\u201369 (2009).","journal-title":"J. Immunol. Methods"},{"key":"54470_CR21","unstructured":"CELL BIOLABS. QuickTiter\u2122 Hepatitis C Core Antigen (HCVcAg) ELISA Kit 2010\u20132024 [Available from: https:\/\/www.cellbiolabs.com\/sites\/default\/files\/VPK-151-hcv-core-antigen-elisa.pdf"},{"key":"54470_CR22","unstructured":"Arigo Biolaboratories. ARG81362 HCV Core antigen \/ HCcAg ELISA Kit [Available from: https:\/\/www.arigobio.com\/HCV-Core-antigen-HCcAg-ELISA-Kit-ARG81362.html"},{"key":"54470_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 30, 429\u2013457 (2012).","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"54470_CR24","doi-asserted-by":"publisher","first-page":"e0010311","DOI":"10.1371\/journal.pntd.0010311","volume":"16","author":"N Salcedo","year":"2022","unstructured":"Salcedo, N., Reddy, A., Gomez, A. R., Bosch, I. & Herrera, B. B. Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development. PLoS Negl. Trop. Dis. 16 (3), e0010311 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"54470_CR25","doi-asserted-by":"crossref","unstructured":"Reddy, A. et al. Development and validation of a rapid lateral flow E1\/E2-Antigen test and ELISA in patients infected with emerging asian strain of Chikungunya virus in the Americas. Viruses ;12(9). (2020).","DOI":"10.3390\/v12090971"},{"issue":"3","key":"54470_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.eimc.2016.11.013","volume":"36","author":"R Alonso","year":"2018","unstructured":"Alonso, R. et al. HCV core-antigen assay as an alternative to HCV RNA quantification: A correlation study for the assessment of HCV viremia. Enferm Infecc Microbiol. Clin. 36 (3), 175\u2013178 (2018).","journal-title":"Enferm Infecc Microbiol. Clin."},{"key":"54470_CR27","doi-asserted-by":"crossref","unstructured":"Inoue, T. et al. Innovative hepatitis C screening: Clinical utility of the HCV antigen-antibody assay in Japan. Jpn J. Infect. Dis. (2025).","DOI":"10.7883\/yoken.JJID.2025.032"},{"key":"54470_CR28","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.21873\/invivo.13234","volume":"37","author":"R Vieira","year":"2023","unstructured":"Vieira, R. et al. HCV Core-antigen assay as an effective alternative to HCV RNA quantification in patients with hepatitis C. VIVO 37, 1498\u20131503 (2023).","journal-title":"VIVO"},{"issue":"4902","key":"54470_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo, Q. L. et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (4902), 359\u2013362 (1989).","journal-title":"Science"},{"issue":"1","key":"54470_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11904-014-0243-7","volume":"12","author":"NA Gogela","year":"2015","unstructured":"Gogela, N. A., Lin, M. V., Wisocky, J. L. & Chung, R. T. Enhancing our understanding of current therapies for hepatitis C virus (HCV). Curr. HIV\/AIDS Rep. 12 (1), 68\u201378 (2015).","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"11","key":"54470_CR31","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/v16111792","volume":"16","author":"P Torre","year":"2024","unstructured":"Torre, P., Festa, M., Sarcina, T., Masarone, M. & Persico, M. Elimination of HCV infection: Recent epidemiological findings, barriers, and strategies for the coming years. Viruses 16 (11), 1792 (2024).","journal-title":"Viruses"},{"key":"54470_CR32","doi-asserted-by":"publisher","first-page":"1225553","DOI":"10.3389\/fmolb.2023.1225553","volume":"10","author":"EJ Vidal-Alc\u00e1ntara","year":"2023","unstructured":"Vidal-Alc\u00e1ntara, E. J. et al. Production and characterization of monoclonal antibodies for the detection of the hepatitis C core antigen. Front. Mol. Biosci. 10, 1225553 (2023).","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"54470_CR33","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1038\/s41467-025-61206-1","volume":"16","author":"AP Cazier","year":"2025","unstructured":"Cazier, A. P. et al. Generating combinatorial diversity via engineered V(D)J-like recombination in Saccharomyces cerevisiae. Nat. Commun. 16 (1), 5688 (2025).","journal-title":"Nat. Commun."},{"issue":"6640","key":"54470_CR34","doi-asserted-by":"publisher","first-page":"eadc9498","DOI":"10.1126\/science.adc9498","volume":"380","author":"EL Shrock","year":"2023","unstructured":"Shrock, E. L. et al. Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses. Science 380 (6640), eadc9498 (2023).","journal-title":"Science"},{"issue":"2","key":"54470_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/15321819508013556","volume":"16","author":"HJ Park","year":"1995","unstructured":"Park, H. J., Byun, S. M., Ha, Y. J., Ahn, J. S. & Moon, H. M. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides. J. Immunoass. 16 (2), 167\u2013181 (1995).","journal-title":"J. Immunoass."},{"issue":"8","key":"54470_CR36","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1128\/jcm.30.8.1989-1994.1992","volume":"30","author":"M S\u00e4llberg","year":"1992","unstructured":"S\u00e4llberg, M., Rud\u00e9n, U., Wahren, B. & Magnius, L. O. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J. Clin. Microbiol. 30 (8), 1989\u20131994 (1992).","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"54470_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/jmv.1890440116","volume":"44","author":"A Sato","year":"1994","unstructured":"Sato, A., Sho, Y., Nakamura, H., Kunitomo, T. & Arima, T. Immune responses of blood donors to peptides of various lengths and those with genotypic sequence variations corresponding to the N-terminal portion of the core protein of hepatitis C virus. J. Med. Virol. 44 (1), 88\u201391 (1994).","journal-title":"J. Med. Virol."},{"issue":"3","key":"54470_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4110\/in.2014.14.3.164","volume":"14","author":"S Kim","year":"2014","unstructured":"Kim, S. et al. Characterization of two novel mAbs recognizing different epitopes on CD43. Immune Netw. 14 (3), 164\u2013170 (2014).","journal-title":"Immune Netw."},{"issue":"6","key":"54470_CR39","doi-asserted-by":"publisher","first-page":"100311","DOI":"10.1016\/j.xcrm.2021.100311","volume":"2","author":"Y Yamaoka","year":"2021","unstructured":"Yamaoka, Y. et al. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests. Cell. Rep. Med. 2 (6), 100311 (2021).","journal-title":"Cell. Rep. Med."},{"issue":"10","key":"54470_CR40","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/jvh.13337","volume":"27","author":"KG Pollock","year":"2020","unstructured":"Pollock, K. G. et al. Real-world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype. J. Viral Hepat. 27 (10), 996\u20131002 (2020).","journal-title":"J. Viral Hepat."},{"key":"54470_CR41","doi-asserted-by":"publisher","first-page":"e4008","DOI":"10.7717\/peerj.4008","volume":"5","author":"R Wasitthankasem","year":"2017","unstructured":"Wasitthankasem, R. et al. HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: Implications for improved diagnostic option in an era of affordable DAAs. PeerJ 5, e4008 (2017).","journal-title":"PeerJ"},{"key":"54470_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/diagnostics14192179","volume":"14","author":"P Ananchuensook","year":"2024","unstructured":"Ananchuensook, P., Wongpiyabovorn, J., Avihingsanon, A. & Tangkijvanich, P. Performance of elecsys(\u00ae) HCV duo immunoassay for diagnosis and assessment of treatment response in HCV patients with or without HIV infection. Diagnostics. 14, 19 (2024).","journal-title":"Diagnostics"},{"issue":"5","key":"54470_CR43","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera, A. J. & Garrett, J. M. Understanding interobserver agreement: The kappa statistic. Fam Med. 37 (5), 360\u2013363 (2005).","journal-title":"Fam Med."},{"issue":"6","key":"54470_CR44","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1128\/JCM.37.6.1802-1808.1999","volume":"37","author":"K Aoyagi","year":"1999","unstructured":"Aoyagi, K. et al. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin. Microbiol. 37 (6), 1802\u20131808 (1999).","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"54470_CR45","doi-asserted-by":"publisher","first-page":"e0287694","DOI":"10.1371\/journal.pone.0287694","volume":"18","author":"P Hansoongnern","year":"2023","unstructured":"Hansoongnern, P. et al. An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA. PLoS One. 18 (6), e0287694 (2023).","journal-title":"PLoS One"},{"issue":"1","key":"54470_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchromb.2006.09.026","volume":"848","author":"AA Shukla","year":"2007","unstructured":"Shukla, A. A., Hubbard, B., Tressel, T., Guhan, S. & Low, D. Downstream processing of monoclonal antibodies\u2013Application of platform approaches. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 848 (1), 28\u201339 (2007).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"issue":"6","key":"54470_CR47","doi-asserted-by":"publisher","first-page":"e04301","DOI":"10.1016\/j.heliyon.2020.e04301","volume":"6","author":"A Kawai","year":"2020","unstructured":"Kawai, A., Yamamoto, Y. & Yoshioka, Y. Vaccine effect of recombinant single-chain hemagglutinin protein as an antigen. Heliyon 6 (6), e04301 (2020).","journal-title":"Heliyon"},{"key":"54470_CR48","unstructured":"Compendium for Successful, S. A. R. T. O. R. I. U. S. A. BLI and SPR Assays: Octet\u00ae Label-Free Biosensor Analysis 2023 [Available from: https:\/\/info.biotechniques.com\/hubfs\/Octet-Label-Free-Biosensor-Analysis-Compendium-en-L-Sartorius.pdf"},{"issue":"6","key":"54470_CR49","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41587-024-02346-5","volume":"43","author":"K Fischer","year":"2025","unstructured":"Fischer, K. et al. Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells. Nat. Biotechnol. 43 (6), 960\u2013970 (2025).","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"54470_CR50","doi-asserted-by":"publisher","first-page":"15448","DOI":"10.1038\/s41598-023-41955-z","volume":"13","author":"LP Arce","year":"2023","unstructured":"Arce, L. P. et al. A multispecies competitive nanobody-based ELISA for the detection of antibodies against hepatitis E virus. Sci. Rep. 13 (1), 15448 (2023).","journal-title":"Sci. Rep."},{"issue":"12","key":"54470_CR51","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","volume":"28","author":"M Kearse","year":"2012","unstructured":"Kearse, M. et al. Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28 (12), 1647\u20131649 (2012).","journal-title":"Bioinformatics"},{"key":"54470_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-2-2","volume":"2","author":"JE Larsen","year":"2006","unstructured":"Larsen, J. E., Lund, O. & Nielsen, M. Improved method for predicting linear B-cell epitopes. Immunome Res. 2, 2 (2006).","journal-title":"Immunome Res."},{"issue":"3\u20134","key":"54470_CR53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"MB SHAPIRO SS, WILK","year":"1965","unstructured":"SHAPIRO SS, WILK, M. B. An analysis of variance test for normality (complete samples)\u2020. Biometrika 52 (3\u20134), 591\u2013611 (1965).","journal-title":"Biometrika"},{"issue":"1","key":"54470_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen, J. A Coefficient of agreement for nominal scales. Educ. Psychol. Meas. 20 (1), 37\u201346 (1960).","journal-title":"Educ. Psychol. Meas."},{"issue":"1","key":"54470_CR55","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s42003-025-08793-3","volume":"8","author":"PB Tonto","year":"2025","unstructured":"Tonto, P. B. et al. Pre-existing YFV-17D immunity mediates T cell cross-protection against dengue virus serotype 2 infection in mice. Commun. Biol. 8 (1), 1334 (2025).","journal-title":"Commun. Biol."},{"issue":"1","key":"54470_CR56","doi-asserted-by":"publisher","first-page":"e13053","DOI":"10.1111\/irv.13053","volume":"17","author":"PB Tonto","year":"2023","unstructured":"Tonto, P. B. et al. High prevalence of IgE sensitization to inactivated influenza vaccines, yet robust IgG4 responses, in a healthy pediatric population. Influenza Other Respir Viruses. 17 (1), e13053 (2023).","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"54470_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02295996","volume":"12","author":"Q McNemar","year":"1947","unstructured":"McNemar, Q. Note on the Sampling Error of the Difference Between Correlated Proportions or Percentages. Psychometrika 12 (2), 153\u2013157 (1947).","journal-title":"Psychometrika"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54470-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:47:12Z","timestamp":1785109632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54470-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54470"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54470-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BBH is a co-founder of Mir Biosciences, Inc., a biotechnology company focused on T cell-based diagnostics and vaccines for infectious diseases, cancer, and autoimmunity. BBH and PBT are co-inventors of a US Provisional Patent Application no. 63\/885,480 \u201cRapid Diagnostic Test for HCV.\u201d","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23315"}}